Residual DNA Testing Market Forecast for Vaccine and Gene Therapy...

agregó una foto Health

2026-04-30 05:19:22 -

Residual DNA Testing Market Forecast for Vaccine and Gene Therapy Growth

Biologics Residual DNA Testing: Ensuring Safety and Quality in Modern Biopharmaceutical Manufacturing Biologics residual DNA testing has become a critical part of modern biopharmaceutical manufacturing, ensuring the safety, purity, and regulatory compliance of complex biological products. As biologics such as monoclonal antibodies, recombinant proteins, vaccines, gene therapies, and cell...

0 Commentarios 0 Acciones 66 Views 0 Vista previa